Open Nav

Session Topics for the 2018 BioSafe European General Membership Meeting will include:

  • PK/TK and Toxicology: Use of Flexible Study Designs
  • Assessment and Management of Immunogenicity: Toxicological and Translational Concepts and Strategies
  • Advanced Therapy Medicinal Products (ATMPs)
  • Nonclinical Investigative Studies
  • CMC Development Challenges and Strategies
  • Challenges in PK/PD and Toxicity Testing: Combination Therapies and Highly Potent Biologics without a relevant Animal Species
  • Hot Topic Breakout Sessions

A preliminary agenda can be found here and is subject to change.